Check here for the latest on COVID-19 diagnosis and treatment
This quality improvement study evaluates the implementation of a patient navigator pilot program to increase attendance at telehealth visits.
This cross-sectional study evaluates subsequent journal publication of COVID-19–related articles initially posted as medRxiv preprints in 2020.
A 12-year-old female individual receives a diagnosis of SARS-CoV-2 and reports bilateral blurry vision, large blue paracentral scotomata, and a migraine without a scintillating scotoma. What would you do next?
This JAMA Forum discusses the problems facing the health care workforce in the wake of the COVID-19 pandemic, including a shortage of workers and the challenge of increasing wages, and highlights issues that policy makers and leaders may consider to address these problems.
This cohort study evaluates hepatitis C virus (HCV) treatment rates and patient characteristics associated with treatment in the era of direct-acting antivirals and during the COVID-19 pandemic.
This cohort study uses a target trial emulation approach to estimate the vaccine effectiveness of a SARS-CoV-2 mRNA booster dose in preventing infection, hospitalization, and death among nursing home residents in the US.
This Medical News feature examines what the COVID-19 pandemic might look like this winter.
This cross-sectional study examines variation by race, ethnicity, and sex of mortality rates of people experiencing homelessness who develop COVID-19 compared with the general population.
This cohort study of patients with COVID-19 compares the incidence rates of viral rebound in patients with COVID-19 treated with molnupiravir or nirmatrelvir-ritonavir.
This meta-analysis reviews the associations between different glucose-lowering therapies and outcomes among patients with diabetes who received therapy before being hospitalized with COVID-19.
This Medical News article explores timely topics discussed at the annual IDWeek conference.
This systematic review and meta-analysis investigates whether female participants and racial and ethnic minority individuals are adequately represented in COVID-19 prevention and treatment trials in the US.
This systematic review and meta-analysis investigates the clinical features and early outcomes associated with myopericarditis after COVID-19 mRNA vaccination in a heterogeneous population of adolescents and young adults.
This randomized clinical trial evaluates the efficacy and safety of pacritinib vs placebo in the treatment of adults with severe COVID-19.
This cohort study examines data for hospital length of stay to determine its association with early use of steroids among pediatric patients hospitalized for COVID-19 who did not have multisystem inflammatory syndrome in children.
This quality improvement study compares telehealth use during the COVID-19 pandemic across clinical specialties at a single institution and assesses the feasibility of asynchronous testing with teleophthalmology.
This JAMA Forum discusses the Biden administration’s recently released National Biodefense Strategy and recommends that the implementation of this national strategy be accompanied by recommendations from the Commonwealth Fund Commission.
This comparative effectiveness study uses health insurance claims data linked to hospital chargemaster data to evaluate the association of remdesivir treatment with inpatient mortality among patients with COVID-19 outside of the clinical trial setting.
Customize your JAMA Network experience by selecting one or more topics from the list below.